IL99701A - History of indole and a pharmaceutical preparation containing them - Google Patents

History of indole and a pharmaceutical preparation containing them

Info

Publication number
IL99701A
IL99701A IL9970191A IL9970191A IL99701A IL 99701 A IL99701 A IL 99701A IL 9970191 A IL9970191 A IL 9970191A IL 9970191 A IL9970191 A IL 9970191A IL 99701 A IL99701 A IL 99701A
Authority
IL
Israel
Prior art keywords
indole
ylmethyl
methylpyrrolidin
hydrogen
alkyl
Prior art date
Application number
IL9970191A
Other languages
English (en)
Hebrew (he)
Other versions
IL99701A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24393510&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL99701(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Priority to IL11511791A priority Critical patent/IL115117A/en
Publication of IL99701A0 publication Critical patent/IL99701A0/xx
Publication of IL99701A publication Critical patent/IL99701A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Lasers (AREA)
  • Electroluminescent Light Sources (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL9970191A 1990-10-15 1991-10-09 History of indole and a pharmaceutical preparation containing them IL99701A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL11511791A IL115117A (en) 1990-10-15 1991-10-09 Indole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59792890A 1990-10-15 1990-10-15

Publications (2)

Publication Number Publication Date
IL99701A0 IL99701A0 (en) 1992-08-18
IL99701A true IL99701A (en) 1996-10-31

Family

ID=24393510

Family Applications (3)

Application Number Title Priority Date Filing Date
IL11511791A IL115117A (en) 1990-10-15 1991-10-09 Indole derivatives
IL9970191A IL99701A (en) 1990-10-15 1991-10-09 History of indole and a pharmaceutical preparation containing them
IL11511795A IL115117A0 (en) 1990-10-15 1995-08-31 Indole derivatives and intermediates thereto

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL11511791A IL115117A (en) 1990-10-15 1991-10-09 Indole derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL11511795A IL115117A0 (en) 1990-10-15 1995-08-31 Indole derivatives and intermediates thereto

Country Status (33)

Country Link
EP (1) EP0592438B1 (no)
JP (2) JP2575272B2 (no)
KR (1) KR0179053B1 (no)
CN (1) CN1039322C (no)
AT (1) ATE157361T1 (no)
AU (1) AU651637B2 (no)
BG (1) BG61975B1 (no)
BR (2) BR9106978A (no)
CA (1) CA2091562C (no)
DE (3) DE10299004I2 (no)
DK (1) DK0592438T5 (no)
EG (1) EG20224A (no)
ES (1) ES2104733T3 (no)
FI (1) FI105812B (no)
GR (1) GR3025087T3 (no)
HU (2) HUT64326A (no)
IE (1) IE913555A1 (no)
IL (3) IL115117A (no)
LU (1) LU90902I2 (no)
MX (1) MX9101606A (no)
MY (1) MY111683A (no)
NL (1) NL300070I2 (no)
NO (3) NO305121B1 (no)
NZ (2) NZ240217A (no)
OA (1) OA09874A (no)
PL (3) PL169987B1 (no)
PT (1) PT99218B (no)
RO (1) RO111767B1 (no)
RU (1) RU2095360C1 (no)
SG (1) SG54270A1 (no)
WO (1) WO1992006973A1 (no)
YU (1) YU48088B (no)
ZA (1) ZA918156B (no)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
UA41297C2 (uk) * 1991-11-25 2001-09-17 Пфайзер, Інк. Похідні індолу, фармацевтична композиція і спосіб лікування
TW288010B (no) * 1992-03-05 1996-10-11 Pfizer
JP2644088B2 (ja) * 1992-04-07 1997-08-25 フアイザー・インコーポレイテツド ５−ｈｔ１作動薬としてのインドール誘導体
AU670270B2 (en) * 1992-04-10 1996-07-11 Pfizer Inc. Acylaminoindole derivatives as 5-HT1 agonists
GB9207930D0 (en) * 1992-04-10 1992-05-27 Pfizer Ltd Indoles
GB9208161D0 (en) * 1992-04-14 1992-05-27 Pfizer Ltd Indoles
GB9210400D0 (en) * 1992-05-15 1992-07-01 Merck Sharp & Dohme Therapeutic agents
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
TW251284B (no) * 1992-11-02 1995-07-11 Pfizer
FR2701026B1 (fr) * 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
IT1271352B (it) * 1993-04-08 1997-05-27 Boehringer Ingelheim Italia Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
KR960701865A (ko) * 1993-04-22 1996-03-28 데이비드 존. 우드 편두통에 사용하는 5-HT1 유사 효능제인 인돌 유도체(Indole Derivatives as 5-HT, -Like Agonists for Use in Migraine)
AP486A (en) * 1993-04-27 1996-04-16 Pfizer Indole derivatives.
ES2070772B1 (es) * 1993-08-09 1996-02-16 Pfizer Derivados de acilaminoindol
ATE170836T1 (de) * 1993-08-31 1998-09-15 Pfizer 5-arylindolderivate
CA2195850A1 (en) * 1994-08-03 1996-02-15 Guillaume Lebaut Substituted indoles
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9420529D0 (en) * 1994-10-12 1994-11-30 Pfizer Ltd Indoles
AU726560B2 (en) * 1994-10-12 2000-11-09 Pfizer Research And Development Company, N.V./S.A. Use of indole derivatives for the treatment of various diseases
DE69528288T2 (de) * 1994-10-12 2003-01-16 Pfizer Ltd., Sandwich Indolderivate zur behandlung von migräne
GB9424471D0 (en) * 1994-12-03 1995-01-18 Pfizer Ltd Treatment of emesis
AU702322B2 (en) * 1995-03-20 1999-02-18 Eli Lilly And Company 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists
GB9510223D0 (en) * 1995-05-20 1995-07-19 Pfizer Ltd Therapeutic agent
US5945118A (en) * 1995-09-29 1999-08-31 Pfizer Inc Indole derivative for the treatment of migraine
GB9714383D0 (en) * 1997-07-08 1997-09-10 Pfizer Ltd Improved process
WO1999053956A1 (fr) * 1998-04-16 1999-10-28 Yamanouchi Pharmaceutical Co., Ltd. Remedes contre l'obesite
GB9816556D0 (en) * 1998-07-30 1998-09-30 Pfizer Ltd Therapy
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
GB9825988D0 (en) 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9922963D0 (en) * 1999-09-28 1999-12-01 Pfizer Ltd Polymorphic salt
JP2000336074A (ja) 1999-03-24 2000-12-05 Sumitomo Chem Co Ltd ［２−（アリールスルホニル）エテニル］ベンゼン誘導体の製造方法
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
CN1382123A (zh) * 1999-08-26 2002-11-27 藤泽药品工业株式会社 吲哚衍生物或其盐的制造方法
GB9923314D0 (en) 1999-10-01 1999-12-08 Pfizer Ltd Acylation process
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
GB0031094D0 (en) * 2000-12-20 2001-01-31 Pfizer Ltd New Process
US20030166704A1 (en) 2000-12-20 2003-09-04 Pfizer Inc. New process
US8329734B2 (en) 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
IL160097A0 (en) 2001-08-15 2004-06-20 Upjohn Co Crystals including a malic acid salt of n-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3h-indole 3-ylidene) methyl]2-(dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof
US7132549B2 (en) 2003-05-30 2006-11-07 Pfizer Inc. Process
GB0312478D0 (en) * 2003-05-30 2003-07-09 Pfizer Ltd Improved process
EP1644004A4 (en) 2003-06-20 2010-10-06 Ronald Aung-Din LOCAL THERAPY FOR THE TREATMENT OF MIGRAINS, MUSCLE CLARIFICATIONS, MUSCLE SPASMS, SPASTICITY AND RELATED CONDITIONS
DE602006012042D1 (de) 2005-06-15 2010-03-18 Pfizer Ltd Substituierte arylpyrazole zur verwendung gegen parasiten
US7645786B2 (en) 2005-06-15 2010-01-12 Pfizer Inc. Substituted arylpyrazoles
WO2006079999A2 (en) * 2006-04-09 2006-08-03 Barth Frederik H Induction of a novel state of mind with a 5-ht2a agonist and a nmda antagonist
US20090299077A1 (en) * 2008-05-22 2009-12-03 Vinod Kumar Kansal Salts of (R)-5-(2phenylsulphonylethenyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole, 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole and of eletriptan
EP2296652B1 (en) 2008-06-30 2017-11-08 Afgin Pharma, Llc Topical regional neuro-affective therapy
EP2149573A1 (en) * 2008-08-01 2010-02-03 Laboratorios Del. Dr. Esteve, S.A. Substituted indole sulfonamide compounds their preparation and use as medicaments
IT1393700B1 (it) * 2009-04-22 2012-05-08 F S I Fabbrica Italiana Sint Sintesi di 3-{[(2r)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1h-indolo
WO2011004391A2 (en) 2009-06-25 2011-01-13 Matrix Laboratories Ltd An improved process for the preparation of eletriptan and its salt thereof
WO2011024039A1 (en) * 2009-08-25 2011-03-03 Ramesh Babu Potluri Synthesis of novel 5-(2-(phenylsulfonyl)ethyl)-1h-indole derivatives
US8754239B2 (en) 2010-01-19 2014-06-17 Sms Pharmaceuticals Limited Process for preparing eletriptan hydrobromide having α-form
CN102606426B (zh) * 2012-03-02 2014-05-21 王仲彦 踏步健身发电装置
WO2014063752A1 (en) 2012-10-26 2014-05-01 Synthon Bv Process for making crystalline form alpha of eletriptan hydrobromide
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
CN103408535B (zh) * 2013-08-13 2016-03-02 张家港威胜生物医药有限公司 一种依来曲普坦中间体-5-溴-3-(n-甲基吡咯啉-2-基甲基)-1h-吲哚合成工艺
MX2017011280A (es) 2015-03-02 2018-06-27 Afgin Pharma Llc Terapia neuro-afectiva regional topica con cannabinoides.
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
WO2017125351A1 (en) 2016-01-21 2017-07-27 Laboratorios Lesvi Sl Process for preparing (( r)-3-[(-1-methylpyrrolidin-2-yl)methyl]-5-(2-phenylsulfonylethyl)-1h-indole
CN106065008B (zh) * 2016-06-16 2018-06-05 黑龙江中医药大学 一种具有改善睡眠作用的吲哚-2-酰胺类化合物及其应用
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene
TR201616365A1 (tr) 2016-11-14 2018-05-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Deksketoprofen ve eletri̇ptanin oral farmasöti̇k kompozi̇syonlari
TR201619983A2 (tr) 2016-12-29 2018-07-23 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Di̇klofenak ve eletri̇ptanin farmasöti̇k formülasyonlari
KR102129947B1 (ko) 2018-06-08 2020-07-03 김종창 콘크리트 타설을 위한 입체형 와이어 메쉬
EP3766483A1 (en) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Orodispersible powder composition comprising a triptan
JP2023511379A (ja) 2020-01-22 2023-03-17 テクノファージ， インベスティガサン エ デセンボルビメント エム ビオテクノロジア，エスエー 脊髄損傷の治療及び移動運動機能の改善のためのエレトリプタン臭化水素酸塩
AU2023215456A1 (en) * 2022-02-01 2024-08-01 Caamtech, Inc. Psychedelic compounds and their therapeutic uses

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL74527C (no) *
US2773875A (en) * 1952-03-28 1956-12-11 Hoffmann La Roche Indole derivatives and method for producing same
GB886684A (en) * 1957-09-17 1962-01-10 Upjohn Co Improvements in or relating to heterocyclic compounds and the manufacture thereof
GB851780A (en) * 1958-02-25 1960-10-19 Rhone Poulenc Sa New indole derivatives
US3037031A (en) * 1959-08-04 1962-05-29 Warner Lambert Pharmaceutical Derivatives of 3-(2-aminoalkyl)-5-indolol and process therefor
GB893707A (en) * 1960-03-01 1962-04-11 Roche Products Ltd Novel tryptamine derivatives and a process for the manufacture thereof
GB966562A (en) * 1961-04-06 1964-08-12 Parke Davis & Co Amine compounds and means of producing the same
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
BE889931A (fr) * 1980-08-12 1982-02-11 Glaxo Group Ltd Derives indoliques, leur preparation et leurs applications en tant que medicaments
US4803218A (en) * 1982-09-29 1989-02-07 Mcneilab, Inc. 3-aminoalkyl-1H-indole-5-urea and amide derivatives
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
CA2091562A1 (en) 1992-04-16
DK0592438T5 (da) 1999-12-06
HUT64326A (en) 1993-12-28
YU165391A (sh) 1994-01-20
PL168919B1 (pl) 1996-05-31
PT99218A (pt) 1992-09-30
DE10299004I1 (de) 2002-05-08
BG97632A (bg) 1994-03-31
NO2001019I1 (no) 2001-12-03
IL99701A0 (en) 1992-08-18
EP0592438B1 (en) 1997-08-27
PT99218B (pt) 1999-04-30
RO111767B1 (ro) 1997-01-30
HU225055B1 (en) 2006-05-29
IL115117A (en) 1996-11-14
EP0592438A1 (en) 1994-04-20
CN1062529A (zh) 1992-07-08
BG61975B1 (bg) 1998-11-30
JPH093063A (ja) 1997-01-07
FI931667A0 (fi) 1993-04-14
GR3025087T3 (en) 1998-01-30
DE69127468D1 (de) 1997-10-02
AU8950491A (en) 1992-05-20
JPH05507288A (ja) 1993-10-21
ES2104733T3 (es) 1997-10-16
NZ240217A (en) 1995-05-26
DK0592438T3 (da) 1997-09-29
CA2091562C (en) 2001-03-27
MY111683A (en) 2000-11-30
MX9101606A (es) 1992-06-05
WO1992006973A1 (en) 1992-04-30
ATE157361T1 (de) 1997-09-15
JP2575272B2 (ja) 1997-01-22
EG20224A (en) 1997-12-31
PL169987B1 (en) 1996-09-30
FI931667A (fi) 1993-04-14
NL300070I2 (nl) 2002-03-01
HU9301098D0 (en) 1993-07-28
NO985607D0 (no) 1998-12-01
SG54270A1 (en) 1998-11-16
BR9106978A (pt) 1993-09-28
YU48088B (sh) 1997-01-08
IE913555A1 (en) 1992-04-22
RU2095360C1 (ru) 1997-11-10
CN1039322C (zh) 1998-07-29
PL170330B1 (pl) 1996-11-29
JP2677777B2 (ja) 1997-11-17
KR0179053B1 (ko) 1999-03-20
DE69127468T2 (de) 1998-01-02
NO931378L (no) 1993-04-14
ZA918156B (en) 1993-04-14
IL115117A0 (en) 1995-12-08
NL300070I1 (nl) 2002-02-01
DE10299004I2 (de) 2006-03-16
NO931378D0 (no) 1993-04-14
FI105812B (fi) 2000-10-13
LU90902I2 (fr) 2002-06-26
AU651637B2 (en) 1994-07-28
BR1100080A (pt) 2000-06-06
NO985607L (no) 1998-12-01
DE9190141U1 (de) 1993-07-15
OA09874A (en) 1994-09-15
NZ270675A (en) 1997-07-27
NO305121B1 (no) 1999-04-06

Similar Documents

Publication Publication Date Title
IL99701A (en) History of indole and a pharmaceutical preparation containing them
US5545644A (en) Indole derivatives
US5578612A (en) Indole derivatives
US6436957B1 (en) Indole derivatives as 5-HT1 agonists
US5607951A (en) Indole derivatives
JPH0633252B2 (ja) インドール誘導体
EP0635015B1 (en) Acylaminoindole derivatives as 5-ht1 agonists
EP1680400A2 (fr) Derives de n-[ phenyl(pyrrolidin-2-yl)methyl]benzamide, et n-[(azepan-2-yl) phenylmethyl]benzamide, leur preparation et leur application en therapeutique
US5717102A (en) Indole derivatives as 5-HT1 agonists
US5559129A (en) Indole derivatives
US5559246A (en) Indole derivatives
EP0785933B1 (en) Indole derivatives as 5ht1-like agonists
US6380233B1 (en) Indole derivatives as 5-HT1 agonists
CA2350089C (en) Indole derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
PEL Intention of commissioner to extend period of protection
EXTP Application for extension order is pending
EXTG Extension of patent term granted
KB Patent renewed
EXTN Extension order renewed
EXTN Extension order renewed
EXTN Extension order renewed
EXTN Extension order renewed
EXTN Extension order renewed